Id |
Subject |
Object |
Predicate |
Lexical cue |
T0 |
0-7 |
IN |
denotes |
Towards |
T1 |
8-17 |
NN |
denotes |
treatment |
T2 |
18-26 |
NN |
denotes |
planning |
T3 |
27-29 |
IN |
denotes |
of |
T4 |
30-38 |
NN |
denotes |
COVID-19 |
T5 |
38-39 |
-COLON- |
denotes |
: |
T6 |
40-49 |
NN |
denotes |
Rationale |
T7 |
50-53 |
CC |
denotes |
and |
T8 |
54-64 |
NN |
denotes |
hypothesis |
T9 |
65-68 |
IN |
denotes |
for |
T10 |
69-72 |
DT |
denotes |
the |
T11 |
73-76 |
NN |
denotes |
use |
T12 |
77-79 |
IN |
denotes |
of |
T13 |
80-88 |
JJ |
denotes |
multiple |
T14 |
89-106 |
JJ |
denotes |
immunosuppressive |
T15 |
107-113 |
NNS |
denotes |
agents |
T16 |
113-114 |
-COLON- |
denotes |
: |
T17 |
115-130 |
NNS |
denotes |
Anti-antibodies |
T18 |
130-131 |
-COMMA- |
denotes |
, |
T19 |
132-147 |
NNS |
denotes |
immunoglobulins |
T20 |
147-148 |
-COMMA- |
denotes |
, |
T21 |
149-152 |
CC |
denotes |
and |
T22 |
153-168 |
NNS |
denotes |
corticosteroids |
T23 |
170-180 |
NNS |
denotes |
Highlights |
T24 |
181-182 |
IN |
denotes |
• |
T25 |
184-188 |
NNP |
denotes |
IVIG |
T26 |
188-189 |
-COMMA- |
denotes |
, |
R0 |
T2 |
T0 |
arg2Of |
planning,Towards |
R1 |
T2 |
T1 |
arg1Of |
planning,treatment |
R10 |
T11 |
T12 |
arg1Of |
use,of |
R11 |
T15 |
T12 |
arg2Of |
agents,of |
R12 |
T15 |
T13 |
arg1Of |
agents,multiple |
R13 |
T15 |
T14 |
arg1Of |
agents,immunosuppressive |
R14 |
T7 |
T16 |
arg1Of |
and,: |
R15 |
T17 |
T18 |
arg1Of |
Anti-antibodies,"," |
R16 |
T19 |
T18 |
arg2Of |
immunoglobulins,"," |
R17 |
T21 |
T20 |
arg1Of |
and,"," |
R18 |
T18 |
T21 |
arg1Of |
",",and |
R19 |
T22 |
T21 |
arg2Of |
corticosteroids,and |
R2 |
T2 |
T3 |
arg1Of |
planning,of |
R20 |
T25 |
T24 |
arg1Of |
IVIG,• |
R21 |
T25 |
T26 |
arg1Of |
IVIG,"," |
R3 |
T4 |
T3 |
arg2Of |
COVID-19,of |
R4 |
T2 |
T5 |
arg1Of |
planning,: |
R5 |
T6 |
T7 |
arg1Of |
Rationale,and |
R6 |
T8 |
T7 |
arg2Of |
hypothesis,and |
R7 |
T7 |
T9 |
arg1Of |
and,for |
R8 |
T11 |
T9 |
arg2Of |
use,for |
R9 |
T11 |
T10 |
arg1Of |
use,the |